# The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.

> **NCT00165711** · PHASE4 · COMPLETED · sponsor: **Eisai Co., Ltd.**

## Conditions studied

- Dementia With Vitamin B12 Deficiency

## Interventions

- **DRUG:** Mecobalamin

## Key facts

- **NCT ID:** NCT00165711
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165711, "The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00165711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*